Get started
Author

Margherita Torti

Constipation in Parkinson's Disease
2017 · Fabrizio Stocchi, Margherita Torti · International review of neurobiology · 134
Anorectal function in multiple system atrophy and Parkinson's disease
2000 · Fabrizio Stocchi, Danilo Badiali, et al. · Movement Disorders · 105
PDF
Rasagiline for the treatment of Parkinson’s disease: an update
2015 · Fabrizio Stocchi, Chiara Fossati, et al. · Expert Opinion on Pharmacotherapy · 47
Advances in dopamine receptor agonists for the treatment of Parkinson’s disease
2016 · Fabrizio Stocchi, Margherita Torti, et al. · Expert Opinion on Pharmacotherapy · 45
Non motor symptoms in progressive supranuclear palsy: prevalence and severity
2017 · Fabiana Giada Radicati, Pablo Martinez Martin, et al. · npj Parkinson s Disease · 42
PDF
Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
2016 · Fabrizio Stocchi, Margherita Torti · Drug Design Development and Therapy · 42
PDF
A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
2014 · Alfredo Cesario, Charles Auffray, et al. · Current Pharmaceutical Design · 35
Istradefylline for the treatment of Parkinson’s disease: is it a promising strategy?
2018 · Margherita Torti, Laura Vacca, et al. · Expert Opinion on Pharmacotherapy · 34
Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study
2020 · Margherita Torti, Chiara Fossati, et al. · PLoS ONE · 33
PDF
Are All Dopamine Agonists Essentially the Same?
2019 · Margherita Torti, Daniele Bravi, et al. · Drugs · 33
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
2025 · Sabrina Paganoni, Christina N. Fournier, et al. · JAMA Network Open · 26
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs
2009 · Lucia Gatta, Alessio Cardinale, et al. · Neuroscience Letters · 24
Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety study
2020 · F. Stocchi, L. Vacca, et al. · European Journal of Neurology · 23
Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study
2019 · C. Warren Olanow, Margherita Torti, et al. · Movement Disorders · 22
Pridopidine in Amyotrophic Lateral Sclerosis
2025 · Douglas Hayden, Po-Ying Lai, et al. · JAMA · 21
Pharmacokinetic drug evaluation of CVT-301 for the treatment of Parkinson’s disease
2018 · Fabrizio Stocchi, Laura Vacca, et al. · Expert Opinion on Drug Metabolism & Toxicology · 19
Therapeutic education for empowerment and engagement in patients with Parkinson’s disease: A non-pharmacological, interventional, multicentric, randomized controlled trial
2023 · Maria Francesca De Pandis, Margherita Torti, et al. · Frontiers in Neurology · 18
PDF
Verdiperstat in Amyotrophic Lateral Sclerosis
2025 · Douglas * deceased Hayden, Po-Ying Lai, et al. · JAMA Neurology · 17
PDF
CNM-Au8 in Amyotrophic Lateral Sclerosis
2025 · Douglas Hayden, Po-Ying Lai, et al. · JAMA · 17
L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised Study
2015 · Fabrizio Stocchi, Laura Vacca, et al. · Parkinson s Disease · 16
PDF
Drug safety evaluation of ropinirole prolonged release
2014 · Fabrizio Stocchi, Fabiana G Radicati, et al. · Expert Opinion on Drug Safety · 13
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial
2025 · Brittney A. Harkey, Sofia Distefano, et al. · Muscle & Nerve · 11
PDF
Continuous Levodopa Delivery with an Intraoral Micropump System: An Open‐Label Pharmacokinetics and Clinical Study
2024 · C. Warren Olanow, Deborah McIntyre, et al. · Movement Disorders · 11
PDF
Safety considerations when using non-ergot dopamine agonists to treat Parkinson’s disease
2020 · Fabrizio Stocchi, Barbara Fossati, et al. · Expert Opinion on Drug Safety · 10
The Impact of Intestinal Microbiota on Weight Loss in Parkinson’s Disease Patients: A Pilot Study
2020 · Federica Del Chierico, Paola Grassini, et al. · Future Microbiology · 8
Works count: 35
Citation count: 817
H-index: 17
I10-index: 24
Year
Topic
Type